Pulse Biosciences
PLSE
#5360
Rank
C$1.56 B
Marketcap
$25.47
Share price
-2.72%
Change (1 day)
241.12%
Change (1 year)
Categories

P/E ratio for Pulse Biosciences (PLSE)

P/E ratio as of November 2024 (TTM): -15.4

According to Pulse Biosciences 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -15.3934. At the end of 2022 the company had a P/E ratio of -1.57.

P/E ratio history for Pulse Biosciences from 2016 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-1.57-75.66%
2021-6.47-41.72%
2020-11.187.86%
2019-5.9113.41%
2018-5.21-62.26%
2017-13.866.47%
2016-8.29

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-37.1 140.98%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-1.33-91.34%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.